Tag Archives: BSTI

Analysts’ View: Worldpay (WP), BEST Inc. (BSTI), Tiffany & Co (TIF)

Brokerage Firm Mizuho upgraded Worldpay, Inc. (NYSE:WP) shares from Neutral to Buy rating.

Worldpay, Inc., through its subsidiary, Vantiv Holding, LLC, provides electronic payment processing services to merchants and financial institutions in the United States.

*

BEST Inc. (NYSE:BSTI) shares were upgraded by analysts at Macquarie from Neutral to Outperform rating.

BEST Inc. operates as a smart supply chain service provider in the People’s Republic of China.

*

Investment Analysts at Oppenheimer upgraded Tiffany & Co. (NYSE:TIF) shares from Perform to Outperform rating.

Tiffany & Co., through its subsidiaries, designs, manufactures, and retails jewelry and other items in the Americas, the Asia-Pacific, Japan, Europe, and internationally.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ Perspective: PayPal (PYPL), BEST Inc. (BSTI), Novartis AG (NVS)

Investment Analysts at Stifel upgraded PayPal Holdings, Inc. (NASDAQ:PYPL) shares from Hold to Buy rating while increasing their price target from $82 to $99.

PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants worldwide.

*

Brokerage Firm Citigroup upgraded BEST Inc. (NYSE:BSTI) shares from Neutral to Buy rating.

BEST Inc. operates as a smart supply chain service provider in the People’s Republic of China.

*

Novartis AG (NYSE:NVS) shares were upgraded by analysts at Credit Suisse from Underperform to Neutral rating.

Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/